参考文献/References:
[1] Koga M,Tatsumoto M,Yuki N,et al.Range of cross reactivity of anti-GM1 IgG antibody in Guillain-Barré syndrome[J].J Neurol Neurosurg Psychiatry,2001,71(1):123-124.
[2] Hotta S,Nakatani Y,Kambe T,et al.Effects of IgG anti-GM1 monoclonal antibodies on neuromuscular transmission and Calcium Channel binding in rat neuromuscular junctions[J].Exp Ther Med,2015,10(2):535-540.
[3] Yoshino H,Ariga T,Suzuki A,et al.Identification of gangliosides recognized by IgG anti-GalNAc-GD1a antibodies in bovine spinal motor neuronsand motor nerves[J].Brain Res,2008,1227:216-220.
[4] 黄诚,秦新月.抗GQlb抗体综合征的研究进展[J].中华神经科杂志,2016,49(1):75-78.
[5] Morgan ML,Law N,Palau AE,et al.Anti-asialo-GM1 and GD1a Variant of Miller Fisher Variant of Guillain-Barre Syndrome[J].Journal of Neuro-Ophthalmology,2014,34(4):377-379.
[6] Harukawa H,Utsumi H,Asano A,et al.Anti-LM1 antibodies in the sera of patients with Guillain-Barre syndrome, Miller Fisher syndrome, and motor neuron disease[J].Journal of the Peripheral Nervous System,2002,7(1):54-58.
[7] Susuki K,Yuki N,Hirata K,et al.Fine specificities of anti-LM1 IgG antibodies in Guillain-Barre syndrome[J].J Neurol Sci,2002,195(2):145-148.
[8] Kuwahara M,Suzuki S,Takada K,et al.Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy[J].J Neuroimmunol,2011,239(1/2):87-90.
[9] Shahrizaila N,Kokubun N,Sawai S,et al.Antibodies to single glycolipids and glycolipid complexes in Guillain-Barr syndrome subtypes[J].American Academy of Neurology,2014,83(2):118-124.
[10] Hayashi R,Yamaguchi S.Guillain-Barre syndrome variant with facial diplegia and paresthesias associated with IgM Anti-GalNAc-GD1a antibodies[J].Internal Medicine,2015,54(3):345-347.
[11] Kaida K,Kusunoki S,Kamakura K,et al.Guillain-Barr syndrome with IgM antibody to the ganglioside GalNAc-GD1a[J].J euroimmunol,2001,113(2):260-267.
[12] Kim OK,Bae JS,Kim DS,et al.Prevalence of Anti-Ganglioside antibodies and their clinical correlates with Guillain-Barre syndrome in Korea: a nationwide multicenter study[J].Journal of Clinical Neurology,2014,10(2):94-100.
[13] Kaida K,Kusunoki S,Kanzaki M,et al.Anti-GQ1b antibody as a factor predictive of mechanical ventilation in Guillain-Barr syndrome[J].Neurology,2004,62(5):821-824.
[14] Yuki N,Ang CW,Koga M,et al.Clinical features and response to treatment in Guillain-Barre syndrome associated with antibodies to GM1b ganglioside[J].Ann Neurol,2000,47(3):314-321.
[15] Kuwabara S,Mori M,Ogawara K,et al.Intravenous immunoglobulin therapy for Guillain-Barr syndrome with IgG anti-GM1 antibody[J].Muscle Nerve,2001,24(1):54-58.
[16] Kaida K,Morita D,Kanzaki M,et al.Ganglioside complexes as new target antigens in Guillain-Barre syndrome[J].Ann Neurol,2004,56(4):567-571.
[17] Kusunoki S,Kaida KI.Antibodies against ganglioside complexes in Guillain-Barre syndrome and related disorders[J].J Neurochem,2011,116(5):828-832.
[18] Samukawa M,Hamada Y,Kuwahara M,et al.Clinical features in Guillain-Barre syndrome with anti-Gal-C antibody[J].J Neurol Sci,2014,337(1/2):55-60.
[19] Devaux JJ.Antibodies to gliomedin cause peripheral demyelinating neuropathy and the dismantling of the nodes of ranvier[J].American Journal of Pathology,2012,181(4):1402-1413.
[20] Ng JK,Malotka J,Kawakami N,et al.Neurofascin as a target for autoantibodies in peripheral neuropathies[J].Neurology,2012,79(23):2241-2248.
[21] Yan WX,Nguyen T,Yuki N,et al.Antibodies to neurofascin exacerbate adoptive transfer experimental autoimmune neuritis[J].J Neuroimmunol,2014,277(1/2):13-17.
[22] Inglis HR,Csurhes PA,Mccombe PA.Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy[J].J Neurol Neurosurg Psychiatry,2007,78(4):419-422.
[23] Gabriel CM,Gregson N,Hughes RA.Anti-PMP22 antibodies in patients with inflammatory neuropathy[J].J Neuroimmunol,2000,104(2):139-146.
[24] Makowska A,Pritchard J,Sanvito L,et al.Immune responses to myelin proteins in Guillain-Barre syndrome[J].J Neurol Neurosurg Psychiatry,2008,79(6):664-671.
[25] Rosch RE,Bamford A,Hacohen Y,et al.Guillain-Barre syndrome associated with CASPR2 antibodies: two paediatric cases[J].Journal of the Peripheral Nervous System,2014,19(3):246-249.
[26] Nakane S,Higuchi O,Hamada Y,et al.Ganglionic acetylcholine receptor autoantibodies in patients with Guillain-Barr syndrome[J].J Neuroimmunol,2016,295:54-59.